Literature DB >> 11258210

Guidelines do matter.

N Anthonisen1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11258210      PMCID： PMC80817     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network.

Authors:  J M Drazen; E Israel; H A Boushey; V M Chinchilli; J V Fahy; J E Fish; S C Lazarus; R F Lemanske; R J Martin; S P Peters; C Sorkness; S J Szefler
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

Review 2.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

3.  Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.

Authors:  A H Anis; L D Lynd; X H Wang; G King; J J Spinelli; M Fitzgerald; T Bai; P Paré
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

4.  Income level and asthma prevalence and care patterns.

Authors:  D Erzen; K C Carriere; N Dik; C Mustard; L L Roos; J Manfreda; N R Anthonisen
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

5.  Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?

Authors:  P Ernst; B Habbick; S Suissa; B Hemmelgarn; D Cockcroft; A S Buist; R I Horwitz; M McNutt; W O Spitzer
Journal:  Am Rev Respir Dis       Date:  1993-07

6.  The use of beta-agonists and the risk of death and near death from asthma.

Authors:  W O Spitzer; S Suissa; P Ernst; R I Horwitz; B Habbick; D Cockcroft; J F Boivin; M McNutt; A S Buist; A S Rebuck
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

7.  Regular inhaled beta-agonist treatment in bronchial asthma.

Authors:  M R Sears; D R Taylor; C G Print; D C Lake; Q Q Li; E M Flannery; D M Yates; M K Lucas; G P Herbison
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.